Skip to main content

Table 1 Baseline characteristics and values of markers of lung injury in survivor versus non-survivors

From: Markers of endothelial and epithelial pulmonary injury in mechanically ventilated COVID-19 ICU patients

Variables

Survivors (n = 20)

Non-survivors (n = 11)

p value

Age, years

61 ± 6

68 ± 6

0.05

Male, sex, no. %

17 (85)

9 (82)

0.59

BMI, Kg/m2

27.8 ± 4.1

28.9 ± 3.2

0.41

SAPS II at ICU admission

27 [21–38]

31 [21–37]

0.55

SOFA score at ICU admission

4 [2–5]

5 [3–6]

0.23

Length of ICU stay (days)

31 [25–43]

24 [16–31]

0.04

Comorbidities

   

Hypertension, no. (%)

9 (45)

8 (73)

0.13

Dyslipidemia, no. (%)

4 (20)

1 (9)

0.40

Former smoker, no. (%)

4 (20)

6 (54)

0.06

Diabetes, no. (%)

4 (20)

1 (9)

0.40

COPD, no. (%)

2 (5)

2 (18)

0.45

Chronic kidney disease, no. (%)

3 (15)

5 (45)

0.08

Laboratory data at inclusion

   

White blood cells, × 103/L

9.8 [7.5–12.9]

10.2 [8.8–12.7]

0.85

Lymphocytes, × 103/L

965 [640–1167]

680 [560–980]

0.18

Hemoglobin, g/dL

12.1 ± 1.8

13.1 ± 1.1

0.11

Platelets count, × 103/L

286 [265–386]

286 [195–332]

0.43

apTT, seconds

39 ± 5

37 ± 5

0.34

INR

1.1 ± 0.1

1.1 ± 0.1

0.35

Fibrinogen mg/dL

708 [655–888]

786 [532–862]

0.87

D-dimer, mcg/mL

31 [14–42]

36 [19–57]

0.31

IL-6, pg/mL

84 [17–149]

60 [37–145]

0.73

Respiratory variables at admission

   

PaO2/ FiO2 ratio

183 [124–264]

116 [81–184]

0.045

PaCO2, mmHg

48 [36–56]

48 [41–69]

0.40

VT/PDW, mL

6.0 ± 0.5

6.0 ± 0.5

0.96

Driving Pressure, cmH2O

9 [8–11]

8 [7–14]

0.79

Compliance Respiratory System

57 [36–78]

60 [51–64]

0.95

Plateau pressure, cmH2O

18 [15–21]

21 [18–23]

0.11

PEEP setting (cmH2O)

12 [9–12]

10 [8–11]

0.07

  1. Data are reported as number (percentage), mean ± standard deviation or median [interquartile range] as appropriate. BMI: body mass index. COPD: chronic obstructive disease. P value: for the comparison between survivors vs non-survivors cases